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ABSTRACT
Cholesterol Modulates Huntingtin Binding to and Aggregation on
Lipid Membranes

Xiang Gao
Huntington disease is an autosomal dominant neurodegenerative disorder. The abnormally
long CAG-repeats in the huntingtin gene that encode an expanded polyglutamine stretch which
promotes self-assemble of huntingtin into different aggregation species that are disease related.
Huntingtin intimately interacts with a variety of lipid membranes. Lipid composition is altered in
HD, especially cholesterol content. Here we investigate how cholesterol content modulates the
interaction between huntingtin and lipid membranes. TBLE/PDA binding assay is performed to
test the binding affinity of huntingtin with lipid bilayers containing different amount of cholesterol.
As the cholesterol content increases, the extent of huntingtin binding to lipid bilayers decreases.
Also, atomic force microscopy (AFM) is used to directly monitor the formation of aggregates on
supported lipid bilayers containing exogenously added cholesterol. Morphological and mechanical
changes in the bilayers exposed to huntingtin are observed by the presence of cholesterol. On pure
TBLE, globular aggregates are formed and grainy in appearance. Most of the bilayers are disrupted.
In contrast, lipid bilayers enriched in different amount of cholesterol facilitate the formation of
plateau-like aggregates with a smooth appearance. With the increase of cholesterol content in lipid
bilayers, the percentage of the surface disrupted by the protein aggregation decreases. In sum, the
presence and amount of cholesterol in lipid bilayers modulates the huntingtin binding and
aggregation on lipid membranes.
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INTRODUCTION
A common feature of neurodegenerative diseases such as Alzheimer’s disease
(AD), Parkinson’s disease (PD), and Huntington’s disease (HD), is the formation of
protein aggregates that deposit in tissues or cellular compartments [1]. Non-native
conformation of specific proteins promotes their self-assembly into insoluble
aggregates. These diseases related aggregates are comprised of extend, ß-sheet rich
fibrils, referred to as amyloid, and thus these diseases are referred to as amyloid disease.
Amyloid formation typically occurs via the nucleation-growth mechanism, which is
comprised of a lag phase and a growth phase [1-3]. However, the assembly process of
aggregates can adopt a myriad of complex aggregation pathways (Figure 1). A variety
of aggregate species (e.g. oligomers, amorphous aggregates, protofibrils, and fibrils)
can be observed along the aggregation pathway.

Figure 1. A generic aggregation scheme for amyloid-forming proteins[4]. Proteins typically
fold into a low-energy native conformation, but sometimes a protein gets trapped in a local energy
minimum associated with a misfolded conformation. This leads directly to protein aggregation
into amyloid fibrils. The aggregation proceeds through several metastable intermediates
including oligomers and protofibrils. Off-pathway aggregates exist, such as the formation of
annular aggregates.
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Environment can influence the formation of protein aggregates, and one such
environmental factor is the presence of surfaces. Conformational changes can be
induced when proteins encounter surfaces [5]. Different aggregate morphologies can
be promoted by different solid surfaces. A classic example of this is the aggregation of
Aβ, a protein associated with Alzheimer’s disease, aggregating on mica [6] or graphite
[7]. While Aβ forms oligomers that coalesce into protofibrils with a beaded morphology
on mica, it forms extended, flat nano-ribbons on graphite that are epitaxially oriented.
Like solid surfaces, lipid membrane can also alter the aggregation process. For most
amyloid proteins, the formation of fibrils is accelerated in the presence of lipid
membranes compared to bulk solution [8-10]. Amyloid-forming proteins can bind
and/or insert into lipid membrane and accumulate within cellular or subcellular
membranes [11, 12], accelerating the nucleation process. Lipid composition within a
membrane can also influence the aggregation process [13].
HD is a progressive neurological disorder. Psychiatric manifestations, cognitive
loss, and chorea [14] are the typical symptoms. Neuronal cell loss occurs mainly in the
cerebral cortex and striatum with up to 30% of brain mass [15]. HD is inherited by a
dominant genetic mutation in an autosomal fashion. The genetic mutation is abnormally
long CAG-repeats in the huntingtin gene which encodes an extended polyglutamine
(polyQ) stretch near the N-terminus of the huntingtin (htt) protein. In brain tissues,
polyQ directly causes htt protein to aggregate into different types of aggregates,
eventually forming cytoplasmic and nuclear inclusion bodies [16] which are the
hallmarks of HD. Inclusion bodies are commonly thought to be the pathological agents
2

by potentially sequestering or incorporating some important proteins [17]. The age of
onset and disease severity are tightly correlated with the length of polyQ with a
threshold ~35 glutamines required for disease [18]. The presence of expanded polyQ
promote the formation of fibrillary structures rich in ß-sheet content (amyloid fibril).
But the assembly of mutant htt into mature amyloid fibril can adopt various aggregation
pathways. There are several metastable intermediate aggregate species along the
pathway such as oligomers and amorphous aggregates, which are associated with
varying degrees of toxicity [19]. It has been suggested that the small diffusible
aggregates like oligomer are more toxic and that the mature fibril are inert or potentially
protective [20]. The most toxic pathologic species remain controversial.
Htt aggregation adopts the nucleation-growth mechanisms. The nucleation event
is critical to the initiation of aggregation; although, the event is a slow process and
thermodynamically

unfavorable.

Once

nucleated,

aggregation

proceeds

by

incorporating htt monomers into different aggregate species leading to the growth phase.
For pure polyQ peptides, the nucleus is thought to be a monomer which undergoes a
conformational change [21]. Once flanking sequences associated with htt are added to
polyQ peptides, a critical tetramer nucleus has been observed [22, 23].
Full length htt is more than 3000 amino acids long and it can be cleaved by several
proteases. Although there are many htt N-terminal fragments, the exon1 has a
potentially important role in HD. Exon1 fragment can be detected in transgenic mice
expressing full length htt [24] and in HD patients [25] due to the aberrant cleavage of
full length htt in polyQ length dependent manner [26]. In knock-in mouse model,
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expression of exon1 with an expanded polyQ leads to a progressive neurological
phenotype [16, 27].

Htt is a multifunctional protein and is present in mammals. Expression of htt is
essential for brain development and neuronal survival [28]. In mouse model, knockout
of htt gene is lethal [29]. Htt plays an important role in vesicle trafficking i.e. the
transport of lipid vesicles (endocytic, synaptic or lysosomal), especially along
microtubules [30-33]. In membrane fractions from brains, htt is detected [34]. Htt can
localize to various subcellular compartments as its normal function [35]. Specifically,
htt binds to ER reversibly and to mitochondria [36, 37]. Htt inclusion bodies incorporate
multi-vesicular membrane into their surfaces [38, 39]. All of this implicates that htt
intimately interacts with various lipid membranes. Although full length htt has multiple
lipid binding sites [40], the highly conserved first 17 amino acid (Nt17) in the N terminus
is thought to target lipid membranes. In the presence of lipid membranes, Nt17 has an
induced α helix structure [41]. Furthermore the flank polyQ domain promotes the
insertion of htt into lipid membrane [42]. Htt disrupts lipid bilayers in a polyQ length
dependent manner [43].

Cholesterol is a main component of biological lipid membranes, especially in
neurons. Approximately 25% of the lipids content in neuronal membranes is cholesterol,
and 70% of myelin sheaths is comprised of cholesterol [44]. All of this indicates that
cholesterol plays an important role in brain tissues. Structurally, cholesterol influences
membrane’s thickness and fluidity [45]. Functionally, the important property of
electrical insulation for neuron cells is related to the cholesterol’s ability to limit ion
4

leakage through membrane [46]. Also, cholesterol affect neurotrophic factors,
transmitter receptors and signal reduction that are specific to neuron cells [47].
Cholesterol does not cross the blood brain barrier, so all the cholesterol in the central
nervous system is synthesized endogenously which is a complex process and can be
affected by many factors.
Altered cholesterol homeostasis is observed in cellular and animal models of HD,
as well as in HD patient tissues [48-50]. Although cholesterol biosynthesis is reduced
in HD, the specifics of altered cholesterol content remains controversial. A decrease in
cholesterol content is reported [51-54] by numerous studies. An increase in cholesterol
levels are also demonstrated by other reports [55-58]. Many of these discrepancies may
be associated with methodology and model systems used to study cholesterol levels in
HD.
The role of htt aggregation in HD is well established; however, investigation of
environmental factors which can influence the aggregation process is still important.
Although the presence of lipid membrane can change htt aggregation, the role of lipid
composition in modulating htt aggregation is poorly understood. The fact that
cholesterol is important to neurons and the hemostasis of cholesterol in HD is altered
indicates that cholesterol may play an important role in HD. Here, we characterize the
interaction of htt exon1 fragments with total brain lipid extract (TBLE) lipid
membranes containing different amount of exogenously added cholesterol.
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METHODS
TBLE/PDA lipid vesicle protein
binding

assay:

Conjugated

polydiacetylene (PDA) is polymer
which has a long conjugation network
and

exhibits

chromatic

properties.

Experiencing surface pressure resulting
in the perturbation of the PDA
dependent side chains, PDA can have a
rapid irreversible blue-red colorimetric
transitions due to a subtle induced
structural transition that shortens the
effective conjugation network of the
backbone of the polymer. Hydrophilic
head group and hydrophobic tail that

Figure 2 colorimetric sensing with TBLE/PDA
vesicles. Structural transformation of PDA (blue)
induced by molecules (green) interacting with lipid
bilayers (grey)

give the PDA lipidomimetic structure promotes lipid/PDA mixing and formation of
biomimetic membrane assemblies. It has been shown that biological analytes primarily
interacting with the lipid domains can still induce the blue-red transformations.
Although the mechanism has not been fully elucidated, it’s been proposed that the
interaction between analytes and lipid domains can influence the structure of PDA
through the lipid/polymer interface. Compared to the moderate blue-red transformation
generated by the deeper penetration into the hydrophobic core, the surface disturbance
6

interacting with the lipid head group can induce more pronounce color transition, i.e.
protein/lipid binding [59](Figure 2). Through the blue-red colorimetric change of the
PDA/lipid vesicles aggregation of amyloid proteins to membrane can be studied [6063]. Furthermore, this transition can be quantified and obtained by determining the
percentage colorimetric response (％CR), defined as [60, 62]

%CR = [(PB0 - PBI)/PB0] × 100

where PB is a red/blue ratio of absorbance (A) defined as Ablue/ (Ablue + Ared). Ablue is
the “blue” component in the UV-vis spectrum (≈640 nm); Ared is the “red”
component (≈500 nm), PB0 is the red/blue ratio of the control sample (before induction
of color change), and PBI is the value obtained for the vesicle solution after addition of
peptides.
Atomic force microscopy: AFM is an important technique for imaging with nanoscale
spatial resolution. Unlike the optical microscopy suffering from the spacial resolution
limitations mainly due to the diffraction limit of light, a cantilever is used to interact
directly with the sample to collect the sample surface information that is used to
reconstruct the sample surface topography. In AFM, the cantilever is allowed to
physically interact with the sample. A laser beam is projected into the sharp tip of the
cantilever and reflected onto a photo detector to generate an optical lever. Through the
optical lever, the vertical movement of the cantilever is amplified and monitored. In
tapping mode AFM, the cantilever is harmonically driven near the resonance frequency.
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When the cantilever interacts with the sample by intermittently making contact at the
bottom of an oscillation cycle, the oscillation amplitude is changed to a tapping
amplitude. By maintaining the tapping amplitude to a pre-determined value, or set-point,
while raster scanning the probe across the surface, the sample topography and other
properties can be characterized. Both height image and phase image can be obtained.
In phase imaging, the shift in the phase of the oscillating probe tip with respect to the
oscillating drive is mapped and provide information about the compositional contrast
of the surface. In solution, local elasticity of lipid membrane can be mapped because of
the sensitivity of phase-shifts to local elastic response [64]. Topographic information is
indicated by the height image while phase image is sensitive to variations in
composition, adhesion, friction, viscoelasticity as well as other factors [64]. In recent
years, AFM has become a particularly useful technique in investigating disease related
protein aggregation process, especially amyloid formation. Furthermore, tapping mode
AFM can work in solution, providing the opportunity to monitor protein aggregation
under physiologically-relevant conditions. From small oligomers to huge mature fibrils,
aggregation species can be observed on surfaces such as lipid membranes [6, 7, 9, 10,
43, 65, 66]. Continuously imaging the same surface area allows for tracking the fate of
individual aggregates and changes in morphology.
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EXPERIMENT PROCEDURES

Figure 3 scheme of fusion protein htt exon1 (Q51) there are 51 glutamine repeats (Q51) and
there is a cleavage site (Factor Xa site) between GST and htt exon1 (Q51)

Purification of GST-htt-exon1 fusion proteins: Expression of GST-htt fusion
proteins was accomplished by transfecting Escherichia coli with the appropriately
designed plasmid (Figure 3). After growing an appropriate concentration of E.coli in
LB broth, isopropyl β-D-thiogalactoside was added to induce the expression of the
fusion protein at 30°C for 4h. The cells were pelleted by centrifugation. Protease
inhibitor was added, and the cells were lysed by adding 0.5 mg/mL lysosome. Ultrasonication was used to further break the cells and release fusion protein. A GST affinity
column was used to purify the lysate by liquid chromatography. Relevant fractions were
collected, and SDS-PAGE electrophoresis was performed to verify the product and
determine purity. Protein was concentrated by centrifugal filter after 48 hours of
dialysis. Pre-existing aggregates were removed by high spin centrifuge at 20,000g for
30min. Cleavage of the GST moiety was achieved by Factor Xa. Cleavage initiates
aggregation. Prior to addition to any lipid membranes, fusion protein and Factor Xa
were incubated on ice for 1 hour to generate enough cleaved htt protein for the assay.
TBLE/PDA lipid vesicle protein binding assay: TBLE (Avanti Polar Lipids),
diacetylene monomers 10,12-tricosadiynoic acid (GFS Chemicals, Columbus, OH) and
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an appropriate amount of cholesterol was dissolved in a solution of 1:1
chloroform/ethanol. The molar ratio of total lipid (TBLE + cholesterol) to PDA was
2:3. Rotary evaporator was used to evaporate the solution, leaving a thin, dry film on
the round bottled flask. 70 °C Tris-buffered saline (TBS) was added to the flask and
sonicated at 100 W using a sonic dismembrator (FisherSci) to resuspend the mixture
and generate TBLE/PDA vesicles. The suspension was stored in a beaker at 4 °C
overnight to ensure self-assembly of vesicles. The diacetylene monomers were
polymerized by irradiation at 254nm with 7 lumens for 10 minutes with stirring,
resulting in a brilliant blue color. Htt-exon1(Q51) and polymerized TBLE/PDA was
added into the wells of 96 well plate. As controls, TBS (negative control) and NaOH
(pH 12) (positive control) were added into the wells containing htt-exon1(Q51). The
final concentration of htt-exon1(Q51) was 20µM in each well. Each experiments were
performed in triplicate in a 96-well format. The colorimetric response of each well was
recorded over 16h using an Infinite M1000 Pro plate reader (TECAN, Switzerland) at
room temperature measuring both the blue component (640nm) and the red component
(500nm) of the spectrum.
Preparation of supported TBLE bilayers for AFM experiments: TBLE (Avanti Polar
Lipids) and cholesterol (Avanti Polar Lipids) were separately dissolved in chloroform
(Fisher Scientific). Based on mass, 10%, 20% or 30% exogenous cholesterol was added
to TBLE. The chloroform was then evaporated off to form a lipid film. These films
were resuspended in PBS at a concentration of 0.5 mg/ml by vortexing and sonication.
A series of 5 freeze-thaw cycles promoted the formation of bilayers and multilayer lipid
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sheets. Bath sonication was then performed for 8 minutes to promote the formation of
lipid vesicles from the lipid sheets. 35µL of the vesicle solution was injected into the
AFM fluid cell and exposed to freshly cleaved mica. By fast continual AFM scanning,
the cantilever aided in fusing the lipid vesicles into a supported lipid bilayer. 35µL of
PBS was then injected into the fluid cell and sucked out three times to remove excess
lipid vesicles.
AFM imaging condition: In situ AFM experiments were performed with a Nanoscope
V MultiMode scanning probe microscope (Bruker, Santa Barbara, CA) equipped with
a sealable fluid cell and a closed-loop “vertical engage” J-scanner. Silicon cantilevers
(VISTA probes) with a nominal spring constant of 0.1 N/m were used to capture images.
Scan rates were set to ~1.95Hz with cantilever drive frequencies ranging from ~4 to 8
kHz. The tapping amplitude was set at about 75% of free amplitude which was ~ 25nm.
AFM images were processed with custom written scripts that use the Matlab image
processing toolbox (Mathworks, Natick, MA).

11

RESULTS
Enriching TBLE with cholesterol
alters the extent of htt-exon1
binding

to

determined

lipid
by

a

vesicles

as

TBLE/PDA

binding assay: To verify that
altering the lipid content of TBLE
would modulate the interaction of
full-length htt-exon1 with lipids,
we

performed

a

TBLE/PDA

vesicle lipid binding assay (Figure
4).

Four

experiments

Figure 4 TBLE/PDA binding assay The percent
colorimetric response (%CR) of TBLE/PDA vesicles
containing various amounts of cholesterol upon
exposure to htt-exon1(51Q) plotted as a function of
time. The highlighted area indicates the timeframe
accessible with AFM experiments described later.

were

performed with TBLE/PDA vesicles enriched with 0% (pure TBLE), 10%, 20%, 30%
exogenous cholesterol by mass. The vesicles were exposed to 20µM htt-exon1 (Q51),
and the colorimetric response was continuously measured for 16 hours. For every
experiment, once the vesicles are exposed to htt-exon1 (Q51) an initial steady increase
in %CR starts. With time, the %CR finally levels off to a stationary state. With
increasing amounts of cholesterol, the initial increase in %CR was less steep, indicating
the binding of htt-exon1 (Q51) to the vesicles was inhibited. Also, as the exogenous
cholesterol content was enriched from 0% to 30%, the final stationary state %CR
decreased, which indicates that the overall protein lipid binding was reduced. Still, there
was significant interaction between htt-exon1 (Q51) and lipid vesicles even for
12

TBLE/PDA vesicles containing 30% exogenous cholesterol.
Cholesterol modulates the morphological and mechanical changes in lipid bilayers
associated with exposure to htt-exon1 (Q51): To investigate the influence of cholesterol
on the aggregation of htt on lipid membranes, supported TBLE bilayers containing
various amounts of cholesterol were exposed to htt-exon1 (51Q) and continuously
imaged using in situ AFM, allowing for the direct tracking of protein aggregation on
the bilayer. Supported lipid bilayer can be formed by fusion of lipid vesicles on the
hydrophilic surface of mica. There are various kinds of forces between the lipid bilayer
and mica which stabilized the bilayer near the surface. However, there is still a gap
between the mica and the bottom leaflet of the bilayer [67]. The supported lipid bilayer
still retains many free membrane properties i.e. lateral fluidity [67]. As a result,
supported lipid bilayers are an appropriate model surfaces to study the interaction of
amyloid-forming proteins with lipid membranes [9, 10, 43, 65, 66]. Height images
(surface topography) and phase images were obtained simultaneously.
For every experiments, only a small size lipid bilayer (10 x 10 µm) was
continuously monitored by AFM. However, a large area (40 x 40 µm in size)
surrounding this small patch of lipid was verified before exposure to htt-exon1 (51Q).
The unperturbed bilayers typically had a RMS roughness value less than 0.2 nm. First,
it was confirmed that stable, supported TBLE enriched with different amounts of
exogenous cholesterol could form smooth, structurally stable bilayers. Bilayers indeed
formed, and there was no indication of distinct lipid domains or structural instability in
either AFM height or phase images for several hours (Figure 5).
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While only a 10 x 10 µm patch was continuously monitored in the AFM
experiments, the scan area was intermittently off-set to image an area of the larger
bilayer that had not been previously imaged. This was done as a control to make sure
that the scanning process was not influencing the aggregation process.

Figure 5 Images of TBLE containing different amount of cholesterol. After several hours
scanning, no nanoscale defects are observed in height and phase images.

For all the experiments, the supported lipid bilayers with varying amounts of added
cholesterol were exposed to freshly prepared aliquots of htt-exon1 (Q51) at a final
protein concentration of 20 µM in the fluid cell. When pure TBLE was exposed to 20
µM solutions of htt-exon1 (Q51), large areas of the bilayer were disrupted extensively
and immediately; although, some small regions appeared unaffected (Figure 6). In the
disrupted regions, RMS surface roughness increased, and discrete aggregates
accumulated. With time, the disrupted areas expanded and became even rougher. The
aggregates also increased in number and size.
In the AFM phase images, there was distinct contrast between the affected
area and unperturbed regions, and this contrast remained consistent during the
120minutes observation. This suggests that there are mechanical differences between
14

these different regions of the bilayer. This observation is consistent with previous
reports that similar morphological changes in bilayers exposed to htt were associated a
decreased compression modulus of the membrane [65, 68].

Figure 6 Sequential AFM height and phase images taken in solution of supported TBLE bilayers
exposed to htt-exon1 (51Q). Blue arrows indicate oligomer-like structures. (B) AFM height
image taken after 120 min demonstrating the rough, grainy morphological changes induced in a
pure TBLE bilayer by htt-exon1 (51Q). Blue line corresponds to the height profile presented
directly below the image.

Of note, the aggregates observed on pure TBLE bilayers were globular in shape. These
oligomers were fairly stable on the membrane, as they could be identified in
consecutive images. Htt-exon1 (Q51) at similar concentrations aggregates into fibrils
in the absence of lipid within an hour; however, there were no fibrils observed during

15

the 2h time course of these experiments. This suggests that the TBLE bilayers can either
stabilize aggregate intermediates or promote the formation of aggregates off the regular
pathway to fibrils.

Figure 7 (A) Sequential AFM height and phase images taken in solution of supported TBLE
bilayers containing 10% exogenously added cholesterol exposed to htt-exon1 (51Q). (B) AFM
height image taken after 120 min demonstrating the smooth morphological changes induced in
a TBLE + 10% cholesterol bilayer by htt-exon1 (51Q). Blue line corresponds to the height
profile presented directly below the image.

Morphologic changes were observed on TBLE bilayers containing 10%
exogenous cholesterol upon exposure to 20 µM htt-exon1 (Q51) that were distinct to
those occurring on pure TBLE systems. Initially, compared to the extensive disruption
on pure TBLE, the disrupted regions were small and more disperse on the bilayer
(Figure 7). Slight increases in height were initially detected in these small domains
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compared to the unperturbed regions. Mechanical changes were also observed on the
lipid bilayer, as indicated by phase images. With time, these domains grew in area and
pronounced increase in their height were observed. Interestingly, as the domain grew,
the phase contrast decreased, suggesting that the perturbed and unperturbed regions of
the bilayer have similar elastic properties.

Figure 8 (A) Sequential AFM height and phase images taken in solution of supported TBLE
bilayers containing 20% exogenously added cholesterol exposed to htt-exon1 (51Q). (B)
Sequential AFM height and phase images taken in solution of supported TBLE bilayers
containing 30% exogenously added cholesterol exposed to htt-exon1 (51Q).

In the pure TBLE bilayer, the aggregates were grainy in appearance, but the
domains in TBLE with 10% cholesterol were plateau-like with a smoother appearance.
While there were a few globular aggregates associated with these plateau-like domains,
17

there was an obvious decrease in the number of such aggregates. The height of the
smoother domain that developed on the TBLE containing exogenous 10% cholesterol
gradually grew from ~1nm to ~4 nm above the regions of unaffected regions.
Similar

morphological

changes in membrane topography
in TBLE bilayers containing added
10% cholesterol were observed in
TBLE bilayers containing 20% and
30%

exogenous

cholesterol

(Figure 8). Specifically, clear
phase contrast was detected at
initial exposure, and small domains
slightly higher than the unaffected
bilayer were observed. With time,

Figure 9 The percent area of disrupted bilayer
morphology associated with exposure of lipid
bilayers containing various amounts of cholesterol
to htt-exon1(51Q) presented as a function of time.
Error bars indicate one standard deviation over three
separate experiments

these domains grew in size and formed a smooth plateau-like domain. The initial
distinct contrast disappeared with the development of the domains in the AFM phase
images. As the cholesterol content increased, surface area disrupted by exposure to httexon1 (Q51) was reduced. Also, the formation of the smooth domain was slowed. The
percentage of surface with altered morphology was used to quantify the interaction of
htt-exon1 (Q51) with the supported lipid bilayers. As cholesterol content increased, the
extent of bilayer disruption decreased in a consistent manner with the PDA binding
assay (Figure 9).
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DISCUSSION
Here, we investigated the role of cholesterol on modulating the interaction
between htt and lipid membranes. Several findings have been reported. The binding of
htt-exon1 (Q51) onto lipid membrane was reduce with the increase of cholesterol
content in membranes. But there was still appreciable binding of htt-exon1 (Q51) to
membranes even with up to 30% exogenously added cholesterol. Morphological and
mechanical change also have been reported. A significant population of globular
aggregates were formed when pure TBLE bilayers was exposed to htt-exon1 (Q51).
The disrupted regions of the bilayer were associated with distinct contrast in AFM
images, indicating altered elastic properties. Compared to grainy disrupted morphology
in pure TBLE bilayers, discrete, thicker domain developed on the bilayer surface with
relatively few globular htt aggregates when cholesterol content was increased.
Furthermore, the extent of bilayer disruption was significantly reduced with increasing
cholesterol content in lipid bilayers upon exposure to htt-exon1 (Q51).
The transcription of cholesterogenic genes is deregulated in HD. In clonal striatalderived cells that overexpress mutant htt, mRNA levels of import genes associated with
cholesterol biosynthesis seem to be reduced [69]. Sterol regulatory element binding
protein can promote transcription of many cholesterol biosynthesis genes, and its
activity is reduced in cell and mouse models of HD. Furthermore, the activity of the
synthetic enzyme HMGCoAR, which is a crucial enzyme in cholesterol biosynthesis
and the level of cholesterol precursors (such as lanosterol and lathosterol), are reduced
from four different HD rodent models [52, 70]. Although the disruption of cholesterol
19

homeostasis in human is generally accepted, accumulation and depletion of cholesterol
are both reported [51-58]. It has been suggested that the limitation on the assays to
quantify cholesterol levels may be responsible for the diverging results [71]. An
increase in cholesterol content, as measured by filipin staining in YAC72 mice, was
observed [72], but the application mass spectrometry techniques to assess absolute
levels of cholesterol and its metabolites indicates a decrease in cholesterol content in
YAC72 mice [70]. A potential decrease in cholesterol content may originate from the
disruption of cholesterol biosynthesis [52, 53, 56, 70]. It is suggested that the potential
accumulation of cholesterol in intracellular spaces derives from the inhibition of
clathrin-independent endocytosis by mutant htt [55]. Intracellular trafficking of
cholesterol is impaired and cholesterol accumulates in cells. The accumulation of
cholesterol in HD cellular and animal models, as in HD human brains, may contribute
to NMDA-mediated excitotoxicity [57]. These finding are limited to cell and animal
modes or postmortem tissues and investigations in HD patients are needed. Despite the
conflicting reports on cholesterol levels in HD, it is demonstrated that cholesterol can
modulate the binding of htt to lipid membrane and aggregate formation. Also, Langmuir
trough and vesicle popping experiments performed in the lab of a collaborator, Shelli
L. Frey, indicate that cholesterol reduces the insertion of htt into lipid membranes and
completely prevents htt-induced permeability of lipid membranes. These observations
justify further studies needed to resolve the controversy about how cholesterol
homeostasis is altered in HD.
Lipid rafts are special membrane domains enriched in lipid cholesterol and
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proteins. In HdhQ111 knock in mouse model, cholesterol accumulates in membrane and
membrane rafts increase when exposed to mutant htt [57]. Here, distinct domains were
observed when mutant htt was exposed to bilayers with excess cholesterol that were
reminiscent in some ways to lipid rafts. It is reasonable to speculate that these plateaulike domains were enriched in both htt and cholesterol. Due to the incorporation of htt
protein into the domains, theses domains are much thicker than normally observed lipid
raft domains in pure lipid bilayer systems [73, 74].
The initial affinity of htt to bind lipid bilayer is impeded by increasing cholesterol
content in lipid membrane. The insertion of htt into lipid monolayers was also inhibited,
as shown by collaborative studies with Shelli L. Frey. A condensation or a stiffening
effect of adding cholesterol to the TBLE system may be a reason for these observations.
Even after the htt binding to or insertion into the lipid membrane, bilayer morphology
and aggregation process also are dependent on the cholesterol content.
Various aggregate species with different structures can be formed from htt. The
polyQ domain in htt can itself adopt variant conformations as a monomer [75] that can
lead to a variety of different aggregates [76]. Distinct monomeric conformation may
play different roles in HD. For example, the monoclonal antibody 3B5H10 recognizes
monomeric species of polyQ that predicts neuronal death in cell culture [77]. Various
aggregates species are associated with varying levels of toxicity. Therefore, it is
plausible that a subset of the aggregate conformers has a prominent role in mediating
pathogenesis in HD. Since the aggregation process can be influenced by a variety of
external factors, it is important to determine how the protein environment promotes the
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formation and stabilization of disease relevant htt conformations. Lipid membranes
represent an important physiologically-relevant factor. The interaction of htt with
membrane surfaces results in altered mechanical integrity of membranes leading to their
dysfunction and stabilization or promotion of specific aggregate species [43, 65, 78]. It
has been found that lipid membranes facilitate the formation of distinct aggregate
species of htt fragments depending on the domains flanking the polyQ stretch [65].
Here, we demonstrate the composition of lipid membranes can modulate the
aggregation of htt. Specifically, the cholesterol content in lipid bilayer promotes the
formation of distinct aggregation species on lipid membranes.
Protein aggregation can disrupt membrane integrity and that is proposed as a
potential mechanism associated with several neurodegenerative diseases. Induced
mechanical changes in lipid membrane could underlie the membrane dysfunction
observed in animal models of HD [4]. Here, it is demonstrated that the bilayer
containing exogenously added cholesterol facilitates the formation of distinct domain
on membrane surfaces upon exposure to htt. Interestingly, these results correlate with
calcium dye leakage experiments which indicate that even a modest increase in
cholesterol can dramatically alters the susceptibility of TBLE membranes to
permeabilization. As the domains observed on membranes containing extra cholesterol
upon exposure to htt have similar elastic properties compared to the unaltered bilayers,
they may be less susceptible to leakage. These mechanical changes may result in a
protective effect of additional cholesterol on the integrity of lipid membranes.
Interestingly, the development of the discrete globular htt aggregates on pure TBLE
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surface exposed to htt-exon1 (Q51) correlates with increased bilayer roughness and
dramatic increases in a lipid bilayer’s susceptibility to permeabilization.

CONCLUSION
As a main component of lipid membrane, cholesterol plays a significant role in
modulating the interaction of htt with lipid membrane. With increasing cholesterol
content in lipid bilayer, the binding affinity decreases. Morphologically, distinct
aggregates are formed on the lipid bilayer. Mechanically, with the addition of
cholesterol in lipid bilayer, the disrupted area and unaffected area have similar
mechanical properties, which may be responsible for the protective ability to reduce
membrane integrity disruption.
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